Fig. 4From: Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapyAssociation of chemotherapy response score (CRS) with overall survival. (blue line: CRS1/2, red line: CRS3)Back to article page